Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men

Journal of the American College of Nutrition

Volumn 22, Issue 5, 2003, Pages 363-371

  Kohut, Marian L ^a   Thompson, James R ^a   Campbell, Jeff ^a   Brown, Greg A ^a   Vukovich, Matthew D ^a   Jackson, Dave A ^a   King, Doug S ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Aging; Androstenedione; Cytokines; DHEA; Hormones; Lymphocyte

Indexed keywords

3 INDOLEMETHANOL; ANDROSTENEDIONE; ESTRADIOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PLACEBO; PRASTERONE; SABAL EXTRACT;

ADULT; AGING; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DRUG EFFECT; HEART PERFORMANCE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INGESTION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NUTRITIONAL STATUS;

ADJUVANTS, IMMUNOLOGIC; ANDROSTENEDIONE; BLOOD CHEMICAL ANALYSIS; CYTOKINES; DEHYDROEPIANDROSTERONE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PLANT PREPARATIONS;

SABAL; SERENOA REPENS; TRIBULUS; TRIBULUS TERRESTRIS;

EID: 0141885304     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2003.10719319     Document Type: Article

References (36)

1. Gray A, Feldman HA, McKinlay JB, Longcope C: Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73:1016-1025, 1991.
2. Miller RA: The aging immune system: primer and prospectus. Science 273:70-73, 1996.
3. Shearer GM: Th1/Th2 changes in aging. Mech Ageing Dev 94: 1-5, 1997.
4. Inserra P, Zhang Z, Aredestani SK, Araghi-Nikman M, Liang B, Jiang S, Shaw D, Moliter M, Elliott K, Watson RR: Modulation of cytokine production by dehydroepiandrosterone (DHEA) plus melatonin (MLT) supplementation of old mice. Proc Soc Exp Biol Med 218:76-82, 1998.
5. Daynes RA, Dudley DJ, Araneo BA: Regulation of murine lymphokine production in vivo II. Dehydroepiandrostenedione is a natural enhancer of interleukin-2 synthesis by helper T cells. Eur J Immunol 20:793-802, 1990.
6. Daynes RA, Araneo BA: Prevention and reversal of some age associated changes in immunologic responses by supplemental DHEAS therapy. Aging Immunol Infect Dis 3:135-154, 1992.
7. Hernandez-Pando R, De La Luz Streber M, Orozco H, Arriaga K, Pavon L, Al-Nakhli SA, Rook GAW: The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunol 95:234-241, 1998.
8. Ben-Nathan D, Lustig S, Kobiler D, Danenberg HD, Lupu E, Feurstein G: Dehydroepiandrosterone protects mice inoculated with West Nile Virus and exposed to cold stress. J Med Virol 38:159-166, 1992.
9. Loria RM, Inge TH, Cook SS, Szaki AK, Regelson W: Protection against lethal viral infection with the native steroid dehydroepiandrostenedione. J Med Virol 26:301-314, 1988.
10. Miller RA, Chrisp C: Lifelong treatment with oral DHEA sulfate does not preserve immune function, prevent disease, or improve survival in genetically heterogenous mice. J Am Geriatr Soc 47: 960-966, 1999.
11. Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Gross DJ, Friedman G: Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J Clin Endocrinol Metab 82:2911-2914, 1997.
12. Degelau J, Guay D, Hallgren MS: The effects of DHEAS on influenza vaccination in aging adults. J Am Geriatr Soc 45:747-751, 1997.
13. Evans TG, Judd ME, Dowell T, Poe S, Daynes RA, Araneo BA: The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine 14:1531-1537, 1996.
14. Khorram O, Vu L, Yen SS: Activation of immune function by dehydroepiandrosterone in age-advanced men. J Gerontol A Biol Sci Med Sci 52:M1-7, 1997.
15. Casson PR, Andersen RN, Herod HG: Oral dehydroepiandrosterone treatment in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 169:1536-1539, 1993.
16. Araneo BA, Dowell T, Diegel M, Daynes RA: Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and _-interferon, but not IL-2 by activated murine T cells. Blood 78:688-699, 1991.
17. Padgett DA, Loria RM: In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J Immunol 153:1544-1552, 1994.
18. Loria RM, Padgett DA, Huynh PN: Regulation of the immune response by dehydroepiandrosterone and its metabolites. J Endocrinol 150:S209-S220, 1996.
19. Ben-Nathan D, Padgett DA, Loria RM: Androstenediol and dehydroepiandrosterone protects mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol 48:425-431, 1999.
20. Mooradian AD, Morley JE, Korenman SG: Biological actions of androgens. Endocr Rev 8:1-28, 1987.
21. Mean F, Pellaton M, Magrini G: Study on the binding of dihydrotestosterone, testosterone and oestradiol with sex hormone binding globulin. Clin Chim Acta 80:171-180, 1977.
22. Sultan C, Terraza A, DeVillier C, Carilla E, Briley M, Lorre C, DeScomps B: Inhibition of androgen metabolism and binding by a liposterolic extract of “Serona repens B” in human foreskin fibroblasts. J Steroid Biochem 20:515-519, 1984.
23. Kellis JT, Vivkery LE: Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225:1032-1034, 1984.
24. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP: Indole-3- carbinol. A novel approach to breast cancer prevention. Ann NY Acad Sci 768:180-200, 1995.
25. Moynihan JA, Callahan TA, Kelley SP, Campbell LM: Adrenal hormone modulation of type 1 and type 2 cytokine production by spleen cells: dexamethasone and dehydroepiandrosterone suppresses interleukin-2, interleukin-4, and interferon-gamma production in vitro. Cell Immunol 184:58-64, 1998.
26. Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S: Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr 130:2927-2931, 2000.
27. Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH: Indole- 3-carbinol induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 24:2927-2936, 2001.
28. Exon JH, South EH, Magnuson BA, Hendrix K: Effects of indole- 3-carbinol on immune responses, aberrant crypt foci, and colonic crypt cell proliferation in rats. J Toxicol Environ Health 62:561-573, 2001.
29. Habtemariam S: Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L929 tumor cells. J Nat Prod 60:775-778, 1997.
30. Plosker GL, Brogden RN: Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging 9:379-395, 1996.
31. Dyner TS, Lang W, Geaga J: An open-label dose-escalation trial of oral DHEA tolerance and pharmacokinetics in patients with HIV disease. J AIDS 6:459-465, 1993.
32. van-Weerden WM, Bierings HG, van-Steenbrugge GJ: Adrenal glands of mouse and rat do not synthesize androgens Life Sci 50:857-861, 1992.
33. Ben-Yehuda A, Danenberg HD, Zakay-Rones Z, Gross DJ, Friedman G: The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly. Mech Ageing Dev 102:299-306, 1998.
34. Brown GA, Vukovich MD, Martini ER, Kohut ML, Franke WD, Jackson DA, King DS: Effects of androstenedione-herbal supplement on serum sex hormone concentrations in 30-59 year old men. Int J Vitam Nutr Res 71:27-31, 2001.
35. Sirrs SM, Bebb RA: DHEA:panacea or snake oil? Can Fam Physician 45:1723-1728, 1999.
36. Brown GA, Vukovich MD, Martini ER, Kohut ML, Franke WD, Jackson DA, King DS: Endocrine responses to chronic androstendione intake in 30-56 year old men. J Clin Endocrinol Metab 85:4074-4080, 2000.